ID PARC_STRPN Reviewed; 823 AA. AC P72525; P72537; Q54917; DT 15-DEC-1998, integrated into UniProtKB/Swiss-Prot. DT 26-SEP-2001, sequence version 3. DT 27-MAR-2024, entry version 165. DE RecName: Full=DNA topoisomerase 4 subunit A {ECO:0000255|HAMAP-Rule:MF_00937}; DE EC=5.6.2.2 {ECO:0000255|HAMAP-Rule:MF_00937}; DE AltName: Full=Topoisomerase IV subunit A {ECO:0000255|HAMAP-Rule:MF_00937}; GN Name=parC {ECO:0000255|HAMAP-Rule:MF_00937}; GN OrderedLocusNames=SP_0855; OS Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4). OC Bacteria; Bacillota; Bacilli; Lactobacillales; Streptococcaceae; OC Streptococcus. OX NCBI_TaxID=170187; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC STRAIN=7785; RX PubMed=8763932; DOI=10.1128/jb.178.14.4060-4069.1996; RA Pan X., Fisher M.; RT "Cloning and characterization of the parC and parE genes of Streptococcus RT pneumoniae encoding DNA topoisomerase IV: role in fluoroquinolone RT resistance."; RL J. Bacteriol. 178:4060-4069(1996). RN [2] RP SEQUENCE REVISION TO 636-643. RA Pan X.; RL Submitted (JAN-2000) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=ATCC BAA-334 / TIGR4; RX PubMed=11463916; DOI=10.1126/science.1061217; RA Tettelin H., Nelson K.E., Paulsen I.T., Eisen J.A., Read T.D., RA Peterson S.N., Heidelberg J.F., DeBoy R.T., Haft D.H., Dodson R.J., RA Durkin A.S., Gwinn M.L., Kolonay J.F., Nelson W.C., Peterson J.D., RA Umayam L.A., White O., Salzberg S.L., Lewis M.R., Radune D., RA Holtzapple E.K., Khouri H.M., Wolf A.M., Utterback T.R., Hansen C.L., RA McDonald L.A., Feldblyum T.V., Angiuoli S.V., Dickinson T., Hickey E.K., RA Holt I.E., Loftus B.J., Yang F., Smith H.O., Venter J.C., Dougherty B.A., RA Morrison D.A., Hollingshead S.K., Fraser C.M.; RT "Complete genome sequence of a virulent isolate of Streptococcus RT pneumoniae."; RL Science 293:498-506(2001). RN [4] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-620. RC STRAIN=D39 / NCTC 7466 / Serotype 2; RX PubMed=8891124; DOI=10.1128/aac.40.10.2252; RA Munoz R., de la Campa A.G.; RT "ParC subunit of DNA topoisomerase IV of Streptococcus pneumoniae is a RT primary target of fluoroquinolones and cooperates with DNA gyrase A subunit RT in forming resistance phenotype."; RL Antimicrob. Agents Chemother. 40:2252-2257(1996). RN [5] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 38-106. RC STRAIN=BM4203; RX PubMed=8913454; DOI=10.1128/aac.40.11.2505; RA Tankovic J., Perichon B., Duval J., Courvalin P.; RT "Contribution of mutations in gyrA and parC genes to fluoroquinolone RT resistance of mutants of Streptococcus pneumoniae obtained in vivo and in RT vitro."; RL Antimicrob. Agents Chemother. 40:2505-2510(1996). RN [6] RP X-RAY CRYSTALLOGRAPHY (2.67 ANGSTROMS) OF 1-488, FUNCTION, CATALYTIC RP ACTIVITY, AND SUBUNIT. RX PubMed=17375187; DOI=10.1371/journal.pone.0000301; RA Laponogov I., Veselkov D.A., Sohi M.K., Pan X.S., Achari A., Yang C., RA Ferrara J.D., Fisher L.M., Sanderson M.R.; RT "Breakage-reunion domain of Streptococcus pneumoniae topoisomerase IV: RT crystal structure of a gram-positive quinolone target."; RL PLoS ONE 2:E301-E301(2007). RN [7] RP X-RAY CRYSTALLOGRAPHY (4.0 ANGSTROMS) OF 1-488. RX PubMed=19448616; DOI=10.1038/nsmb.1604; RA Laponogov I., Sohi M.K., Veselkov D.A., Pan X.S., Sawhney R., RA Thompson A.W., McAuley K.E., Fisher L.M., Sanderson M.R.; RT "Structural insight into the quinolone-DNA cleavage complex of type IIA RT topoisomerases."; RL Nat. Struct. Mol. Biol. 16:667-669(2009). RN [8] RP X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 1-488 IN COMPLEX WITH PARE; RP LEVOFLOXACIN AND DNA, CATALYTIC ACTIVITY, FUNCTION, ACTIVE SITE, ACTIVITY RP REGULATION, AND SUBUNIT. RX PubMed=20596531; DOI=10.1371/journal.pone.0011338; RA Laponogov I., Pan X.S., Veselkov D.A., McAuley K.E., Fisher L.M., RA Sanderson M.R.; RT "Structural basis of gate-DNA breakage and resealing by type II RT topoisomerases."; RL PLoS ONE 5:E11338-E11338(2010). CC -!- FUNCTION: Topoisomerase IV is essential for chromosome segregation. It CC relaxes supercoiled DNA (PubMed:17375187, PubMed:20596531). Performs CC the decatenation events required during the replication of a circular CC DNA molecule. {ECO:0000255|HAMAP-Rule:MF_00937, CC ECO:0000269|PubMed:17375187, ECO:0000269|PubMed:20596531}. CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP-dependent breakage, passage and rejoining of double- CC stranded DNA.; EC=5.6.2.2; Evidence={ECO:0000255|HAMAP-Rule:MF_00937, CC ECO:0000269|PubMed:17375187, ECO:0000269|PubMed:20596531}; CC -!- ACTIVITY REGULATION: Inhibited by quinolones, such as levofloxacin CC (PubMed:20596531). {ECO:0000269|PubMed:20596531}. CC -!- SUBUNIT: Heterotetramer composed of ParC and ParE (PubMed:17375187, CC PubMed:20596531). {ECO:0000255|HAMAP-Rule:MF_00937, CC ECO:0000269|PubMed:17375187, ECO:0000269|PubMed:20596531}. CC -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000255|HAMAP-Rule:MF_00937}; CC Peripheral membrane protein {ECO:0000255|HAMAP-Rule:MF_00937}. CC -!- SIMILARITY: Belongs to the type II topoisomerase GyrA/ParC subunit CC family. ParC type 2 subfamily. {ECO:0000255|HAMAP-Rule:MF_00937}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; Z67739; CAA91551.2; -; Genomic_DNA. DR EMBL; AE005672; AAK74984.1; -; Genomic_DNA. DR EMBL; X95717; CAA65021.1; -; Genomic_DNA. DR EMBL; U49088; AAB08038.1; -; Genomic_DNA. DR PIR; G95098; G95098. DR PDB; 2NOV; X-ray; 2.67 A; A/B/C/D=1-488. DR PDB; 3FOE; X-ray; 4.00 A; A/B=1-488. DR PDB; 3FOF; X-ray; 4.00 A; A/B=1-488. DR PDB; 3K9F; X-ray; 2.90 A; A/B=1-488. DR PDB; 3KSA; X-ray; 3.30 A; A/B=1-488. DR PDB; 3KSB; X-ray; 3.50 A; A/B=1-488. DR PDB; 3LTN; X-ray; 3.10 A; A/B=1-488. DR PDB; 3RAD; X-ray; 3.35 A; A/B=1-488. DR PDB; 3RAE; X-ray; 2.90 A; A/B=1-488. DR PDB; 3RAF; X-ray; 3.24 A; A/B=1-488. DR PDB; 4I3H; X-ray; 3.70 A; A/B=1-490. DR PDB; 4JUO; X-ray; 6.53 A; A=1-488. DR PDB; 4KOE; X-ray; 3.02 A; A/B=1-488. DR PDB; 4KPE; X-ray; 3.43 A; A/B=1-488. DR PDB; 4KPF; X-ray; 3.24 A; A/B=1-488. DR PDB; 4Z3O; X-ray; 3.44 A; A/B=3-484. DR PDB; 4Z4Q; X-ray; 3.04 A; A/B=3-484. DR PDB; 4Z53; X-ray; 3.26 A; A/B=3-484. DR PDBsum; 2NOV; -. DR PDBsum; 3FOE; -. DR PDBsum; 3FOF; -. DR PDBsum; 3K9F; -. DR PDBsum; 3KSA; -. DR PDBsum; 3KSB; -. DR PDBsum; 3LTN; -. DR PDBsum; 3RAD; -. DR PDBsum; 3RAE; -. DR PDBsum; 3RAF; -. DR PDBsum; 4I3H; -. DR PDBsum; 4JUO; -. DR PDBsum; 4KOE; -. DR PDBsum; 4KPE; -. DR PDBsum; 4KPF; -. DR PDBsum; 4Z3O; -. DR PDBsum; 4Z4Q; -. DR PDBsum; 4Z53; -. DR AlphaFoldDB; P72525; -. DR SMR; P72525; -. DR DIP; DIP-48521N; -. DR IntAct; P72525; 1. DR ChEMBL; CHEMBL2363033; -. DR DrugBank; DB06771; Besifloxacin. DR DrugBank; DB01044; Gatifloxacin. DR DrugCentral; P72525; -. DR PaxDb; 170187-SP_0855; -. DR EnsemblBacteria; AAK74984; AAK74984; SP_0855. DR KEGG; spn:SP_0855; -. DR eggNOG; COG0188; Bacteria. DR PhylomeDB; P72525; -. DR BioCyc; SPNE170187:G1FZB-873-MONOMER; -. DR EvolutionaryTrace; P72525; -. DR PRO; PR:P72525; -. DR Proteomes; UP000000585; Chromosome. DR GO; GO:0005694; C:chromosome; IEA:InterPro. DR GO; GO:0019897; C:extrinsic component of plasma membrane; IEA:UniProtKB-UniRule. DR GO; GO:0005524; F:ATP binding; IEA:InterPro. DR GO; GO:0003677; F:DNA binding; IEA:UniProtKB-UniRule. DR GO; GO:0003918; F:DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity; IEA:UniProtKB-UniRule. DR GO; GO:0007059; P:chromosome segregation; IEA:UniProtKB-UniRule. DR GO; GO:0006265; P:DNA topological change; IEA:UniProtKB-UniRule. DR CDD; cd00187; TOP4c; 1. DR Gene3D; 3.30.1360.40; -; 1. DR Gene3D; 2.120.10.90; DNA gyrase/topoisomerase IV, subunit A, C-terminal; 1. DR Gene3D; 3.90.199.10; Topoisomerase II, domain 5; 1. DR Gene3D; 1.10.268.10; Topoisomerase, domain 3; 1. DR HAMAP; MF_00937; ParC_type2; 1. DR InterPro; IPR006691; GyrA/parC_rep. DR InterPro; IPR035516; Gyrase/topoIV_suA_C. DR InterPro; IPR013760; Topo_IIA-like_dom_sf. DR InterPro; IPR013758; Topo_IIA_A/C_ab. DR InterPro; IPR013757; Topo_IIA_A_a_sf. DR InterPro; IPR002205; Topo_IIA_dom_A. DR InterPro; IPR005741; TopoIV_A_Gpos. DR NCBIfam; TIGR01061; parC_Gpos; 1. DR PANTHER; PTHR43493; DNA GYRASE/TOPOISOMERASE SUBUNIT A; 1. DR PANTHER; PTHR43493:SF9; DNA TOPOISOMERASE 4 SUBUNIT A; 1. DR Pfam; PF03989; DNA_gyraseA_C; 5. DR Pfam; PF00521; DNA_topoisoIV; 1. DR SMART; SM00434; TOP4c; 1. DR SUPFAM; SSF101904; GyrA/ParC C-terminal domain-like; 1. DR SUPFAM; SSF56719; Type II DNA topoisomerase; 1. DR PROSITE; PS52040; TOPO_IIA; 1. PE 1: Evidence at protein level; KW 3D-structure; Cell membrane; DNA-binding; Isomerase; Membrane; KW Reference proteome; Topoisomerase. FT CHAIN 1..823 FT /note="DNA topoisomerase 4 subunit A" FT /id="PRO_0000145418" FT DOMAIN 30..496 FT /note="Topo IIA-type catalytic" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01384" FT ACT_SITE 118 FT /note="O-(5'-phospho-DNA)-tyrosine intermediate" FT /evidence="ECO:0000255|HAMAP-Rule:MF_00937, FT ECO:0000269|PubMed:20596531" FT SITE 38 FT /note="Interaction with DNA" FT SITE 74 FT /note="Interaction with DNA" FT SITE 76 FT /note="Interaction with DNA" FT SITE 87 FT /note="Interaction with DNA" FT SITE 93 FT /note="Interaction with DNA" FT SITE 117 FT /note="Transition state stabilizer" FT CONFLICT 95 FT /note="R -> C (in Ref. 5; AAB08038)" FT /evidence="ECO:0000305" FT CONFLICT 257 FT /note="I -> T (in Ref. 1; CAA91551 and 4; CAA65021)" FT /evidence="ECO:0000305" FT CONFLICT 362 FT /note="R -> P (in Ref. 4; CAA65021)" FT /evidence="ECO:0000305" FT CONFLICT 373 FT /note="H -> R (in Ref. 4; CAA65021)" FT /evidence="ECO:0000305" FT CONFLICT 401 FT /note="A -> P (in Ref. 4; CAA65021)" FT /evidence="ECO:0000305" FT CONFLICT 473 FT /note="K -> N (in Ref. 4; CAA65021)" FT /evidence="ECO:0000305" FT CONFLICT 589 FT /note="E -> A (in Ref. 4; CAA65021)" FT /evidence="ECO:0000305" FT CONFLICT 608 FT /note="V -> A (in Ref. 4; CAA65021)" FT /evidence="ECO:0000305" FT STRAND 4..8 FT /evidence="ECO:0007829|PDB:3K9F" FT HELIX 9..26 FT /evidence="ECO:0007829|PDB:3K9F" FT TURN 27..29 FT /evidence="ECO:0007829|PDB:3RAF" FT TURN 33..35 FT /evidence="ECO:0007829|PDB:3K9F" FT HELIX 39..50 FT /evidence="ECO:0007829|PDB:3K9F" FT HELIX 62..72 FT /evidence="ECO:0007829|PDB:3K9F" FT HELIX 78..88 FT /evidence="ECO:0007829|PDB:3K9F" FT TURN 91..93 FT /evidence="ECO:0007829|PDB:3K9F" FT STRAND 98..103 FT /evidence="ECO:0007829|PDB:3K9F" FT TURN 116..118 FT /evidence="ECO:0007829|PDB:3K9F" FT STRAND 120..123 FT /evidence="ECO:0007829|PDB:3K9F" FT HELIX 125..130 FT /evidence="ECO:0007829|PDB:3K9F" FT TURN 131..133 FT /evidence="ECO:0007829|PDB:3K9F" FT HELIX 134..136 FT /evidence="ECO:0007829|PDB:3K9F" FT STRAND 141..143 FT /evidence="ECO:0007829|PDB:3K9F" FT STRAND 147..154 FT /evidence="ECO:0007829|PDB:3K9F" FT HELIX 161..165 FT /evidence="ECO:0007829|PDB:3K9F" FT STRAND 167..170 FT /evidence="ECO:0007829|PDB:3K9F" FT STRAND 175..178 FT /evidence="ECO:0007829|PDB:3K9F" FT HELIX 183..195 FT /evidence="ECO:0007829|PDB:3K9F" FT STRAND 196..198 FT /evidence="ECO:0007829|PDB:3KSB" FT HELIX 201..207 FT /evidence="ECO:0007829|PDB:3K9F" FT STRAND 218..220 FT /evidence="ECO:0007829|PDB:3K9F" FT HELIX 222..231 FT /evidence="ECO:0007829|PDB:3K9F" FT STRAND 232..239 FT /evidence="ECO:0007829|PDB:3K9F" FT STRAND 241..247 FT /evidence="ECO:0007829|PDB:3K9F" FT TURN 248..250 FT /evidence="ECO:0007829|PDB:3K9F" FT STRAND 251..258 FT /evidence="ECO:0007829|PDB:3K9F" FT HELIX 265..277 FT /evidence="ECO:0007829|PDB:3K9F" FT STRAND 280..283 FT /evidence="ECO:0007829|PDB:3K9F" FT STRAND 286..289 FT /evidence="ECO:0007829|PDB:3K9F" FT STRAND 298..301 FT /evidence="ECO:0007829|PDB:3K9F" FT HELIX 308..318 FT /evidence="ECO:0007829|PDB:3K9F" FT STRAND 322..328 FT /evidence="ECO:0007829|PDB:3K9F" FT STRAND 330..333 FT /evidence="ECO:0007829|PDB:3K9F" FT STRAND 336..339 FT /evidence="ECO:0007829|PDB:3K9F" FT HELIX 342..383 FT /evidence="ECO:0007829|PDB:3K9F" FT HELIX 385..394 FT /evidence="ECO:0007829|PDB:3K9F" FT STRAND 395..397 FT /evidence="ECO:0007829|PDB:3K9F" FT HELIX 398..409 FT /evidence="ECO:0007829|PDB:3K9F" FT HELIX 413..420 FT /evidence="ECO:0007829|PDB:3K9F" FT HELIX 424..428 FT /evidence="ECO:0007829|PDB:3K9F" FT HELIX 432..454 FT /evidence="ECO:0007829|PDB:3K9F" FT HELIX 456..474 FT /evidence="ECO:0007829|PDB:3K9F" FT STRAND 480..482 FT /evidence="ECO:0007829|PDB:3K9F" SQ SEQUENCE 823 AA; 93133 MW; D4D17BD5DED63C05 CRC64; MSNIQNMSLE DIMGERFGRY SKYIIQDRAL PDIRDGLKPV QRRILYSMNK DSNTFDKSYR KSAKSVGNIM GNFHPHGDSS IYDAMVRMSQ NWKNREILVE MHGNNGSMDG DPPAAMRYTE ARLSEIAGYL LQDIEKKTVP FAWNFDDTEK EPTVLPAAFP NLLVNGSTGI SAGYATDIPP HNLAEVIDAA VYMIDHPTAK IDKLMEFLPG PDFPTGAIIQ GRDEIKKAYE TGKGRVVVRS KTEIEKLKGG KEQIVIIEIP YEINKANLVK KIDDVRVNNK VAGIAEVRDE SDRDGLRIAI ELKKDANTEL VLNYLFKYTD LQINYNFNMV AIDNFTPRQV GIVPILSSYI AHRREVILAR SRFDKEKAEK RLHIVEGLIR VISILDEVIA LIRASENKAD AKENLKVSYD FTEEQAEAIV TLQLYRLTNT DVVVLQEEEA ELREKIAMLA AIIGDERTMY NLMKKELREV KKKFATPRLS SLEDTAKAIE IDTASLIAEE DTYVSVTKAG YIKRTSPRSF AASTLEEIGK RDDDRLIFVQ SAKTTQHLLM FTSLGNVIYR PIHELADIRW KDIGEHLSQT ITNFETNEEI LYVEVLDQFD DATTYFAVTR LGQIKRVERK EFTPWRTYRS KSVKYAKLKD DTDQIVAVAP IKLDDVVLVS QNGYALRFNI EEVPVVGAKA AGVKAMNLKE DDVLQSGFIC NTSSFYLLTQ RGSLKRVSIE EILATSRAKR GLQVLRELKN KPHRVFLAGA VAEQGFVGDF FSTEVDVNDQ TLLVQSNKGT IYESRLQDLN LSERTSNGSF ISDTISDEEV FDAYLQEVVT EDK //